PAUL FRANCIS: Open Payments
NPI 1154088482 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,588 in 84 payments from 16 companies in 2025. Trend: 2023 $1,074 · 2024 $1,193 · 2025 $1,588
Food & beverage: $1,573Education: $15
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 20 | $407 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $218 |
| Lundbeck LLC | 11 | $195 |
| Alkermes, Inc. | 12 | $185 |
| Teva Pharmaceuticals USA, Inc. | 7 | $129 |
| E.R. Squibb & Sons, L.L.C. | 5 | $95 |
| Neurocrine BioSciences, Inc. | 5 | $89 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
Products named: HETLIOZ, CAPLYTA, ARISTADA, REXULTI, FANAPT, COBENFY, INGREZZA, UZEDY.
Industry payments across KY — which companies pay providers there.
